when was glp-1 discovered Metabolic Messengers: glucagon-like peptide 1 History of GLP-1 Medications -

So far most of the trials in this area have been small and led by academic investigators

Use of topiramate by patients on a ketogenic diet may also result in a physiological environment that increases the likelihood of kidney stone formation

Both compounds should be stored UN-reconstituted at 20C and reconstituted with bacteriostatic water prior to use in laboratory protocols

GLP-1 medications were initially developed to treat type 2 diabetes, but their use has expanded to several other indications, including weight loss, cardiovascular risk reduction and obstructive sleep apnoea

All donors gave written informed consent and protocols were approved by the ethical review board of Fundao Hospitalar de Hematologia e Hemoterapia do Amazonas (CAEE: 51257921.2.0000.0009, approval number #4.982.395/2021)